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The variability in Helicobacter pylori vacA and cagA genes has been related to the progression of the gastrointestinal disease; also
the presence ofH. pylori in the oral cavity has been associated with periodontal disease in adults, but, in children without dyspeptic
symptoms, little is known about this. We evaluated the prevalence ofH. pylori and the presence of vacA/cagA genotypes in the oral
cavity of Mexican children without dyspeptic symptoms. The gingival status was measured, and dental plaque samples (𝑛 = 100)
were taken. 38% of children were positive for H. pylori 16S rRNA gene by qPCR. A significant association between H. pylori oral
infection and gingival status was observed (𝑃 < 0.001). In 34.6% (9/26) of mild gingivitis cases, s1m2 genotype was found, while
s1m1was typed in 50% (3/6) ofmoderate gingivitis.The cagA prevalence amongH. pylori-positive childrenwas 80.8% (21/26), 83.3%
(5/6), and 16.7% (1/6) of cases of mild gingivitis, moderate gingivitis, and nongingivitis, respectively (𝑃 < 0.001). The s1m1/cagA+
combinational genotype was the most detected in children with gingivitis. Our results suggest that the prevalence of H. pylori
and detection of vacA/cagA genotypes-associated gastrointestinal disease in the oral cavity could be related to the progression of
gingivitis in asymptomatic children.
1. Introduction
Helicobacter pylori is a Gram-negative species which colo-
nizes gastricmucosa in humans [1].H. pylori infection is asso-
ciated with gastrointestinal tract diseases including chronic
gastritis, peptic ulcer, mucosa-associated lymphoproliferative
disorders, and gastric cancer [2–4]. The global prevalence of
H. pylori infection is more than 50%. This prevalence may
vary significantly within and among countries, according to
geography, ethnicity, age, and socioeconomic factors [5, 6]. It
has been reported thatH. pylori infection rate is up to 70% in
developing countries, while the rates in developed countries
and regions, such as Australia and Western Europe, are
only 25% and 28%, respectively [7]. Socioeconomic factors
also explain a significant proportion of the difference in H.
pylori prevalence. In the third National Health and Nutrition
Examination Survey conducted in the United States, a 25%
prevalence of H. pylori infection was found in children and
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young adults between 6 and 19 years. In the American popu-
lation, prevalencewas 42%; prevalencewas higher in children
of a low socioeconomic status, in those whose mothers had
a lower education level, and in those living in crowded
conditions [8]. O’Rourke et al. evaluated the H. pylori infec-
tion in Mexican and American children living on both sides
of the Rio Grande (a river that is dividing both countries);
a slightly higher prevalence was observed in Mexicans com-
pared to Americans [9]. In a similar study by Goodman et
al. they found a seroprevalence of 74% and 56% of Mexican
and American women, respectively [10]. The relationship
between socioeconomic status and H. pylori infection has
been reported too in countries such as Bolivia [11].
Epidemiologic studies have shown evidence that most
infections are acquired in childhood, but the specific age
of acquisition and the factors associated with its persistence
are not clear [12]. In developing countries, 70 to 90% of the
population become infected during childhood; in developed
countries, a smaller percentage (∼10%) of children become
infected, and the prevalence of infection increases with age
[10]. InMexico, a seroepidemiological national survey in 1998
found a national prevalence of 66% in the general population,
20% in children younger than one year, 50% in children
younger than ten years, and 70% in adults younger than 20
years.There were differences in prevalence, depending on the
economic development of the regions (86.1% prevalence in
southeastern Mexico, 47.1% in the northeast) [13].
H. pylori infection mainly spreads through consumption
of contaminated food and drinks or is transmitted orally.
Several studies have evaluated the oral cavity, and H. pylori
has been detected in dental plaque and saliva [14–16]. It is
known that the presence of H. pylori in the oral cavity is one
of the main causes of the reappearance of gastric H. pylori
infection and that treatment of oral infection significantly
increases eradication of H. pylori infection in the stomach
[17]. Nevertheless, the role of dental plaque as an extragastric
reservoir in H. pylori transmission is controversial [18–20].
Also, the oralH. pylori infection has been related to oral cavity
problems, like gingivitis, periodontitis [21, 22], and recurrent
aphthous stomatitis (RAS) [23]. Nisha et al. showed a highly
significant association was found between periodontal dis-
ease and colonization of H. pylori in dental plaque [24].
H. pylori has many virulence factors that allow establish-
ment, colonization, and damage to the gastric epithelium.
An important virulence factor secreted by H. pylori is VacA
cytotoxin, which induces vacuolization and cell death in
epithelial cells. The encoding vacA gene is present in all
H. pylori strains, but it is polymorphic, comprising variable
signal regions (type s1 or s2) and midregions (type m1 or
m2) [3, 26]. Strains with alleles s1/m1 secrete an active toxin
that is associated with the development of peptic ulcers and
gastric cancer; also, this region was recently described as a
determining factor in cytotoxicity and development of gastric
disorders [27]. Some strains of H. pylori produce the CagA
cytotoxin, as part of the cag pathogenicity island (PAI), a
region of 40 kb DNA encoding about 31 genes that make
up a type IV secretion system, which allows the release of
oncoprotein CagA directly to the cytosol of gastric epithelial
cells [28]. Upon release, CagA leads to dephosphorylation
of cellular proteins, changes in morphology, increased cell
proliferation, chronic inflammation, and carcinogenesis pro-
cesses [29]. It is reported that individuals infected with cagA-
positive and certain cagA alleles (e.g., cagA1a) have a higher
risk of developing the peptic ulcer and gastric cancer [30].
Recently, some studies have evaluated the prevalence of
H. pylori cagA and vacA genes in saliva and dental plaque
[31–33], but its frequency has not been extensively studied in
Mexico.
In this study, we evaluated the prevalence of H. pylori
and the presence of vacA genotypes and cagA gene in dental
plaque of Mexican children without dyspeptic symptoms.
2. Materials and Methods
2.1. Patients. From November to December 2015, one hun-
dred Mexican children (from 3 to 16 years old) from the
Back2Back nonprofit organization at Monterrey city, Nuevo
Leo´n, Mexico, were selected to participate in this study. The
exclusion criteria were as follows: (1) current history of anti-
biotic usage or during the previous two months, (2) systemic
disease, (3) dyspeptic symptoms, and (4) history of gastroin-
testinal diseases. Before selection, the informed consent form
was obtained from guardians and authorities, who declared
the willingness of children to allow the use of the samples
and anonymous data for research purposes, and also this
study was approved byThe Research Bioethics Committee in
Dental Science College at Universidad Auto´noma de Nuevo
Leo´n (UANL).
2.2. Measurement of Gingivitis. The modified gingival index
(MGI), defined by Lobene et al., is a noninvasive method (no
probing) [34].TheMGIwas used to assess gingival inflamma-
tion in participants, as follows: (0)normal (no inflammation),
(1)mild inflammation (slight change in color, little change in
texture) of any portion of the gingival unit, (2) mild inflam-
mation of the entire gingival unit, (3)moderate inflammation
(moderate glazing, redness, edema, and/or hypertrophy) of
the entire gingival unit, and (4) severe inflammation (marked
redness and edema/hypertrophy, spontaneous bleeding, or
ulceration) of the gingival unit. The clinical examination was
performed by the same observer.
2.3. Sample Collection. Dental plaque was collected with a
sterile bamboo skewer by a downward scrape against the
vestibular surface (supragingival) of the superior first molar.
After that, the sample was suspended in 1.5ml of trypticase
soy broth (TS; Becton Dickinson, Franklin Lakes, NJ) sup-
plemented with 30% (w/v) glycerol for the maintenance of
microbial viability and then storage at −70∘C, until use.
2.4. DNA Extraction. Dental plaque samples were cen-
trifuged at 12,000×g for 2min, then washed with 0.01m
Phosphate-Buffered Saline (PBS; 0.1m, pH 7.4), and sus-
pended in 100 𝜇l Tris-EDTAbuffer (TE; 10mMTris and 1mM
EDTA, at pH 7.4). For enzymatic cell lysis, 10 𝜇l of lysozyme
(10mg/ml) and 10 𝜇l of Proteinase K (10mg/ml) were added
and incubated at 56∘C for 30min. Total DNA was extracted
using a High Pure PCR template preparation kit (Roche
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Diagnostics, GmbH, Mannheim, Germany) according to
the manufacturer’s recommendations and the DNA concen-
tration was measured at 260 nm in a spectrophotometer
(NanoDrop 8000 UV-Vis; Thermo Scientific, Wilmington,
DE). The DNA samples were stored at −20∘C, until use.
2.5. Detection of H. pylori and cagA Gene by qPCR. The
presence of H. pylori and cagA status were assessed by
qPCR using primers/probe for 16s rRNA gene and cagA
gene, respectively (Table 1). The qPCR primers/probes were
designed by IDT PrimerQuest tool (http://www.idtdna.com/
primerquest/), DNA sequences were obtained from the Gen-
Bank database (https://www.ncbi.nlm.nih.gov/genbank/), and
BLAST search (http://blast.ncbi.nlm.nih.gov/)was performed
to check the specificity of the primers/probe sequences.
The efficiency of primer pairs and probes was evaluated by
performing serial dilutions from 0.1 to 100 ng of DNA, and
the value of the slopewas obtained by simple linear regression
analysis (R2); the primers and probes showed≥95% efficiency
values. The qPCR reactions were performed in a 96-well
plates containing 12.5 𝜇L of 2x maxima probe qPCR master
mix (Thermo Scientific, Carlsbad, California, USA), 0.3𝜇M
primers mix forward/reverse, 0.2𝜇M probe, and 100 ng of
the DNA sample, in free-nucleases water to a final volume
of 25 𝜇L; 100 ng of DNA from H. pylori ATCC 700824 or
ATCC43504 strains and nuclease-free water were added as
positive and negative control, respectively. The qPCR assay
was carried out in a LightCycler 480II thermocycler (Roche,
Mannheim, Germany). The thermocycler was programmed
with a monocolor hydrolysis probe format (6-FAM, filter
combination 465–510) as follows: one denaturalization cycle
(95∘C, 10min), thirty-five amplification cycles (95∘C, 10 s,
4∘C/s ramp rate; 55∘C, 15 s, 2∘C/s ramp rate; 72∘C, 15 s, 4∘C/s
quantification analysis ramp rate), one melting cycle (95∘C,
5 s, 4∘C/s ramp rate; 65∘C, 1min, 2.2∘C/s ramp rate, 97∘Cwith
a 5∘C continuous acquisition), and one cooling cycle (40∘C,
10 s, 1.5∘C/s ramp rate).
2.6. Detection of H. pylori vacA Alleles. The vacA gene and
“s” and “m” region genotyping was performed by nested PCR
using a set of oligonucleotides for each gene fragment, as
previously described by Koehler et al. [25]. For the signal
region (s) detection, vacA1F/vacA1R and vacA2F/vacA1R
oligonucleotides were used in the first and the second ampli-
fication rounds, respectively. For the middle region 1 (m1)
allele detection in the first round m1F1/m1R1 primers were
used; for the second round, m1F2 and m1R2 were used. For
middle region 2 (m2), m2F1/m2R1 and m2F2/m2R2 primers
were employed in the first and the second runs, respectively
(Table 1).
All the PCR were prepared using 1x NH
4
reaction buffer,
3mMMgCl
2
, 10 𝜇M of each deoxynucleoside triphosphate,
0.2 𝜇Mof each primer, 2.5 units Taq Polymerase (BiolineUSA
Inc., Taunton, USA), and 200 ng of DNA up to a final volume
of 25 𝜇L. The PCR were carried out in MJ Mini Thermal
Cycler (Bio-Rad Lab).The PCR program comprised 1 cycle of
initial denaturation (95∘C, 5min), 35 cycles of denaturation
(95∘C, 1min), annealing (58∘C, 1min) and extension (72∘C,
1min), and 1 cycle of final extension (72∘C, 5min). For the
second amplification round, 1 𝜇l DNA template from the
first PCR and 0.2 𝜇M of each primer were used. PCR was
performed according to the PCR protocol described above.
The PCR products were visualized on 8% (v/v) acrylamide
gel (Bio-Rad Lab) in Tris-Borate-EDTA buffer (TBE; 40mM
Tris, 45mM boric acid, 1mM EDTA, at pH 7.4). The gel was
stainedwith 1𝜇g/mLof ethidiumbromide solution and trans-
ferred to ultraviolet transilluminator (Gel Doc XR+ Imager;
Bio-Rad Lab). The sizes of the amplicons were estimated
by comparison with a DNA size marker (Quick-Load 2-
Log DNA Ladder; New England Biolabs, MA, USA). 120 bp
and 150 bp PCR products corresponded to s1 and s2 alleles,
respectively, while 301 bp and 102 bp bands corresponded to
m1 and m2 alleles, respectively. H. pylori ATCC43504 strain
was used as positive control (Figure 1).
2.7. Statistical Analysis. The association between H. pylori
oral infection and each nominal variable were determined
by the Chi-square and Fisher’s exact tests; one-way ANOVA
tests, post hoc Tukey tests, or Student’s 𝑡-tests were used for
numeric variables. The 𝑃 < 0.05 value was considered statis-
tically significant. The data were analyzed using SPSS IBM
statistics software v22.0.
3. Results
3.1. The History of Participants and H. pylori Detection. This
study was designed to determine the frequency of H. pylori
cagA and vacA genes in dental plaque of children from
the northeastern Mexico. A total of 100 children without
gastric clinical manifestations, 50 males and 50 females
ranging in age from 3 to 16 years with an average age
of 8.95 ± 3.72, were included. Also, the participants were
divided according to the gingival clinical presentation, 59
(59.0%) were diagnosed as no inflammation, 35 (35.0%) were
diagnosed as mild inflammation, and 6 (6.0%) were regarded
as moderate inflammation (Table 2). Among 41 gingivitis
cases, 62.1% (22/35) of mild inflammation cases were male,
while 83% (5/6) ofmoderate inflammation cases were female.
A significant difference (𝑃 < 0.05) was observed between the
mean age of patients withmoderate inflammation (4.83±2.04
years old) and thosewhodid not present inflammation (9.47±
3.42 years old), as shown in Table 3.
The detection of H. pylori 16S rRNA gene by qPCR
revealed that 38% of samples were positive. AmongH. pylori-
positive children, 55.3% (21/38) and 44.7% (17/38) were male
and female, respectively. The mean age of H. pylori-positive
individuals was 8.37 ± 4.17 years (Table 2).
3.2. Relationship between the H. pylori Oral Infection and
the Gingival Clinical Presentation. A significant association
between H. pylori oral detection and gingival status was
observed (𝑃 < 0.001). 68.4% (26/38) of H. pylori-positive
children shown mild inflammation, while 15.8% (6/38)
showed no inflammation; all of the cases of moderate inflam-
mation were positive (Table 2).
3.3. Frequency of H. pylori vacA Alleles and Association of
Genotypes with the Gingival Clinical Presentation. The vacA
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Table 1: PCR primers and probes used for detection and genotyping of H. pylori.
Gen 5󸀠-3󸀠 sequence Product size(bp) Reference
16S rRNA
F: GATAGTCAGTCAGGTGTGAAATCC
196
In this study
R: GTTTGCTCCCCACGCTTT
Probe: AAAATCCGTAGAGATCAAGAGGA
cagA
F: GACCGACTCGATCAAATAGCA
113R: TTAGCTGAAAGCCCTACCTTAC
Probe: AGTGGTTTGGGTGATGTAGGGCAA
vacA s
vacA1F: CTGGT(C/T)TAAAGTCGCACCCTTTGTGC
s1: 120
s2: 150
Koehler et al. [25]
vacA1R: CAATGGCTGGAATGATCACGGTTGT(A/G)
vacA2F: CAAACACACCGCAAAATCAATCGCCC
vacA m1
m1F1: CAACAATCAAGGCACTATCAA(C/T)TA
301m1R1: CCGCATGCTTTAATGTCATCAG
m1F2: TGGTCCGAGGCGGG(A/C)AAGT
m1R2: TCATCAGTATTTCGCACCACAC
vacA m2
m2F1: TTTGGAGC(C/T)CCAGGAAACATTG
102m2R1: C(C/T)ACACGCCCATCTTGGACAA
m2F2: ACCCTAAA(C/T)AGCAACGCAAGC
m2R2: GACAAAAAGATTCATCGTGCCTT
150 bp s2
120 bp s1
300 bp
400 bp
200 bp
100 bp
M 1 2 3 4 5 6 7 M
(a)
301 bpm1300 bp
400 bp
200 bp
100 bp
M 1 2 3 4 5 6 7
(b)
102 bpm2
300 bp
200 bp
100 bp
M 1 2 3 4 5 6 7 M
(c)
Figure 1: Results of the gel electrophoresis for identification of H. pylori vacA alleles and genotypes in dental plaque samples of Mexican
children. (a) Detection of 𝑠 alleles. Lane M, molecular weight marker 0.1 to 10 kb (BioLabs Inc.); lane 1, positive control (DNA fromH. pylori
ATCC 43504 s1m1 genotype); lanes 2-3, positive control (DNA from gastric biopsy with H. pylori s2m2 genotype); lane 4, negative control
(without DNA); lane 5, s2 allele positive (DNA from sample); lane 6, s1 allele positive (DNA from sample); lane 7, s1 and s2 alleles positive
(DNA from sample). (b) Detection of m1 allele. Lane M, molecular weight marker 0.1 to 10 kb (BioLabs Inc.); lane 1, positive control (DNA
from H. pylori ATCC 43504 s1m1 genotype); lane 2, negative control (without DNA); lane 3, m1 allele negative (DNA from sample); lanes
4–7, m1 allele positive (DNA from sample). (c) Detection of m2 alleles. Lane M, molecular weight marker 0.1 to 10 kb (BioLabs Inc.); lane 1,
positive control (DNA from gastric biopsy with H. pylori vacA s2m2 genotype); lane 2, negative control (without DNA); lanes 3 and 7, m2
allele negative (DNA from sample); lanes 4–6,m2 allele positive (DNA from sample).
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Table 2: Prevalence of H. pylori in dental plaque fromMexican children by gender and age and the gingival clinical presentation.
Total𝑁 = 100 H. pylori 16S rRNA gene 𝑃 value
Positive𝑁 = 38 Negative𝑁 = 52
Gender 𝑛 (%)
Female 50 (50.0) 17 (44.7) 33 (53.2)
0.41a
Male 50 (50.0) 21 (55.3) 29(46.8)
Age
Mean (±SD) 8.95 (±3.72) 8.37 (±4.17) 9.31 (±3.4) 0.2425b
Age groups 𝑛 (%)
3–5 21 (21.0) 12 (31.6) 9 (14.5)
0.084a
6–8 33 (33.0) 10 (26.3) 23 (37.1)
9–11 14 (14.0) 2 (5.3) 12 (19.4)
12–14 26 (26.0) 12 (31.6) 14 (22.6)
15-16 6 (6.0) 2 (5.3) 4 (6.5)
MGI 𝑛 (%)
No inflammation 59 (59.0) 6 (15.8) 53 (85.5)
<0.001cMild inflammation 35 (35.0) 26 (68.4) 9 (14.5)
Moderate inflammation 6 (6.0) 6 (15.8) 0
aChi-square test. bStudent’s 𝑡 test. cExact Fisher test. MGI: modified gingival index.
Table 3: Distribution of the gingival clinical presentation by gender and age.
Modified gingival index
𝑃 valueNo inflammation
𝑁 = 59
Mild inflammation
𝑁 = 35
Moderate inflammation
𝑁 = 6
Gender 𝑛 (%)
Female 32 (54.2) 13 (37.1) 5 (83.3)
0.078a
Male 27 (45.8) 22 (62.1) 1 (16.7)
Age
Mean (±SD) 9.47 (±3.42) 8.77 (±4.02) 4.83 (±2.04) 0.012b
Age groups 𝑛 (%)
3–5 8 (13.6) 10 (28.6) 3 (50.0)
0.135a
6–8 22 (37.3) 8 (22.9) 3 (50.0)
9–11 11 (18.6) 3 (8.6) 0
12–14 14 (23.7) 12 (34.3) 0
15-16 4 (6.8) 2 (5.7) 0
aExact Fisher test. bOne-way ANOVA test.
allelic variants were determined in patients with dental
plaque H. pylori-positive, as shown in Figure 1. The vacA
s1 and m1 alleles were most frequent for the signal and
middle region, respectively. The vacA s1m2 genotype was
the most common among H. pylori-positive patients, with
28.9% (11/38), followed by s1m1 genotypes with 26.3% (10/38)
(Table 4). The coinfection of s1m1 with s2m1 was observed
in 13.2% (5/38) of H. pylori-positive samples. In 5.3% (2/38)
of patients, the s1 allele was detected, but the 𝑚 region was
undetectable (s1m0); the s2 allele was identified in 1 patient,
but the𝑚 region could not be identified (s2m0).
The prevalence of vacA genotypes and alleles varied with
gingival status. The s2m1 genotype was detected in 50%
(3/6) of H. pylori-positive children without gingivitis. In
34.6% (9/26) of mild inflammation cases, s1m2 genotype
was found, while s1m1 allele combination was typed in 50%
(3/6) of moderate inflammation (Table 4). The coinfection of
s1m1/s1m2was observed only in patientswith gingivitis (4 and
1 for mild and moderate inflammation, resp.).
3.4. Association between the Presence of H. pylori cagA
Gene and Gingival Clinical Presentation. We found that the
prevalence of cagA gene was 27% (27/100). In 71.1% (27/38) of
H. pylori-positive samples, cagA gene was detected (Table 4).
The cagA gene status has shown a significant relationshipwith
gingival status (𝑃 < 0.001). Also, the cagA prevalence among
H. pylori-positive children was 80.8% (21/26), 83.3% (5/6),
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Table 4: Distribution of vacA genotypes, cagA status, and combinational vacA/cagA genotypes in dental plaque from H. pylori-positive
children with gingival clinical presentation.
Total
𝑁 = 38
H. pylori-positive
No inflammation
𝑁 = 6
Mild inflammation
𝑁 = 26
Moderate inflammation
𝑁 = 6
aV𝑎𝑐𝐴 alleles 𝑛 (%)
s1 31 (81.6) 3 (50.0) 22 (84.6) 6 (100.0)
s2 10 (26.3) 3 (50.0) 6 (23.1) 1 (16.7)
m1 24 (63.2) 4 (66.7) 15 (57.7) 5 (83.3)
m2 16 (42.1) 1 (16.7) 13 (50.0) 2 (33.3)
m0 3 (7.9) 1 (16.7) 2 (7.7) 0
vacA genotypes
s1m1 10 (26.3) 1 (16.7) 6 (23.1) 3 (50.0)
s1m2 11 (28.9) 1 (16.7) 9 (34.6) 1 (16.7)
s2m1 6 (15.8) 3 (50.0) 3 (11.5) 0
s1m0 2 (5.3) 1 (16.7) 1 (3.8) 0
s2m0 1 (2.6) 0 1 (3.8) 0
b𝑠1m1/s1m2 5 (13.2) 0 4 (15.4) 1 (16.7)
b𝑠1m1/s2m1 3 (7.9) 0 2 (7.7) 1 (16.7)
cagA status
Positive 27 (71.1) 1 (16.7) 21 (80.8) 5 (83.3)
Negative 11 (28.9) 5 (83.3) 5 (19.2) 1 (16.7)
vacA/cagA genotypes
s1m1/cagA+ 9 (23.7) 1 (16.7) 5 (19.2) 3 (50.0)
s1m1/cagA− 1 (2.6) 0 1 (3.8) 0
s1m2/cagA+ 5 (13.2) 0 5 (19.2) 0
s1m2/cagA− 5 (13.2) 1 (16.7) 3 (11.5) 1 (16.7)
s2m1/cagA+ 4 (10.5) 0 4 (15.4) 0
s2m1/cagA− 3 (7.9) 3 (50.0) 0 0
s1m1/s1m2/cagA+ 4 (10.5) 0 3 (11.5) 1 (16.7)
s1m1/s2m1/cagA+ 3 (7.9) 0 2 (7.7) 1 (16.7)
s1m1/s2m1/cagA− 1 (2.6) 0 1 (3.8) 0
cUndetermined 3 (7.9) 1 (16.7) 2 (7.7) 0
aFrequency and percentages based on H. pylori-positive patients. bCoexistence of genotypes; cV𝑎𝑐𝐴 genotypes with m0 alleles; m0: nontypeable for middle
region.
and 16.7% (1/6) of cases ofmild gingivitis,moderate gingivitis,
and nongingivitis, respectively.
The combinational s1m1/cagA+ genotype was detected in
23.7% (9/38) of H. pylori-positive children. The same geno-
typic combination of vacA/cagA was the most frequent in
children with gingivitis (5/26 and 3/6 of cases with mild and
moderate gingivitis, resp.), while s2m1/cagA− combinational
genotype was most prevalent in children without gingivitis
(Table 4).
4. Discussion
It has been demonstrated that H. pylori infection is a risk
factor for the development of gastric pathologies, including
gastric cancer [4]. Several studies of H. pylori prevalence
have shown the strong association with sociodemographic
and socioeconomic factors where the developing countries
are usually themost affected [8, 10–13].The gastric infection is
mainly acquired during the first years of life, where common
symptoms are not present. Several studies have concluded
that the high frequency of H. pylori could be due to its
multiple mechanisms of transmission, where the oral cavity
plays a determinant role as a source of transmission to other
hosts and a focus for the continuous gastric reinfection after
eradication therapy [14]. However, some researchers do not
agree with this approach.
In this study, the detection ofH. pylori and cagA gene was
performed by qPCR.The use of TaqMan qPCR probes would
allow accurate identification of H. pylori and would prevent
the detection in the oral cavity of other microorganisms
that are close phylogenetically to H. pylori, as Campylobacter
species [35]. Our results show that 38% of dental plaque
samples from children were H. pylori-positive. All partici-
pants were apparently healthy and did not report any gastric
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disease at the time of the evaluation (Table 2). Our results
agree with those found by Duque et al. and those reported by
Mendoza et al., both studies in Mexican school children, but
these reports used urea breath test (UBT) for the diagnosis
of infection [8, 36]. The agreement would be attributed to
the fact that both diagnosis methods (UBT and PCR) have
an estimated sensitivity of 75% to 100%. However, PCR has
a higher specificity than UBT due to the presence of other
urease-producing microorganisms in the stomach [37]. In
2014, Valdez-Gonzalez et al. evaluated the presence of H.
pylori in dental plaques of 40 Mexican children using qPCR,
and 35% of the samples were positive [16]. Our results are
different from those reported by Castro-Mun˜oz et al.; they
studied 162 asymptomatic Mexican children, and 13% of oral
swab sample (from inside cheeks) were positive by PCR
[15]. This difference may be due to the site from which
samples were collected because the detection rates in dental
plaques were more than those in other locations of oral
cavity [14]. Zheng and Zhou evaluated the detection rate of
H. pylori in subgingival and supragingival plaque samples
from adults with/without periodontitis, and they observed
a higher detection rate in subgingival plaques than that in
supragingival plaques (𝑃 < 0.05) [22]. In our study, supragin-
gival plaque samples were taken because it is a noninvasive
sampling method (not probing) for children. It is possible
that the microaerobic conditions and microbial associations
in dental plaque could favor the persistence ofH. pylori in the
oral cavity, constituting an ideal site for sampling inH. pylori
oral detection studies.
The presence of H. pylori in oral cavity would provide a
foundation for a role in H. pylori transmission. Miyabayashi
et al. investigated the effect of oral H. pylori on the stomach.
The investigators observed that their patients with oral H.
pyloriwere found to be at a significantly higher risk for gastric
reinfection after having received adequate treatment. The
authors also determined that drugs used for the eradication of
the gastricH. pylori did not affect the oralH. pylori [38].Most
published studies have reported the oral cavity (dental plaque
and saliva) as a source for subsequent gastric infections or
reinfections in the same patient and as a reservoir for oral-
oral transmission [19, 39]. However, some authors suggest
that H. pylori is a microorganism transitory in the human
oral cavity [40]. The mechanism by which H. pylori reaches
the oral cavity is unknown. It is possible that the occasional
reflux from the gastric reservoir allows colonization of the
oral cavity. It is also possible that the reverse is true.
Our results indicate a significant frequency of H. pylori
in dental plaque of asymptomatic children where the dental
plaque would act as a reservoir for oral-oral dispersal to
the population. However, our results cannot confirm the
bacterial viability of oral H. pylori nor the ability to transmit
to other individuals. This subject requires considerably more
investigation due to the fact that the involvement of dental
plaque in the transmission ofH. pylori can be confirmed and
that new measures can be tailored toward the prevention of
oral spread.
It has been demonstrated that exposure to an H. pylori-
positive family is a risk factor for persistence of infection in
children under five years. Cervantes et al. followed a large
cohort of children throughout the first years of life and
concluded that when siblings are close in age, the older sibling
may be an important source of H. pylori transmission for
younger siblings [41]. In our study, we observed that 31.6%
of H. pylori-positive subjects corresponded to the groups of
age from 3 to 5 years (12/38) and 12 to 14 years (12/38). The
children come from a care center for orphans where the
coexistence between the older children and the younger ones
would have favored the transmission among the children.
However, this possibility could not be confirmed in this study.
On the other hand, other studies have reported the familial
transmission between parents and children [42, 43]. After
many years of research, very little is known about the details
of the modes of transmission ofH. pylori and its propagation
pathways.The primary modes of transmission are thought to
be fecal-oral and oral-oral, but some indirect evidence has
also been published for transmission via drinking water and
other environmental sources [44].
Dental plaque harbors at least 400 different bacterial
species and forms a biofilm inwhich organisms are intimately
associatedwith each other and embedded in an exopolymeric
matrix (salivary polymers and microbial extracellular prod-
ucts). This biofilm adheres to supragingival and subgingival
tooth surfaces [19].The accumulation ofmicroorganisms and
increased concentration of bacterial metabolites in gingiva
induces an inflammatory process, called gingivitis. Gingivitis
is one of the first clinical manifestations of the periodontal
disease [45]. H. pylori oral infection has been related to
oral pathologies, including gingivitis/periodontal disease,
aphthous stomatitis, and oral cancer [5]. In this study, a
significant relationship between the presence of H. pylori
in dental plaque and the gingival clinical presentation was
found (Table 2). In 1999, in Great Britain, Riggio and Lennon
demonstrated the presence of H. pylori in 11/29 (38%)
subgingival plaques of patients with chronic periodontitis.
They suggested that, in this patient group at least, subgingival
plaquemay be a reservoir forH. pylori infection [46]. In 2012,
Agarwal and Jithendra found that 60% of the samples were
H. pylori-positive by PCR in periodontitis group compared
to 15% in without-periodontitis group [47]. In Mexico, there
are few reports about this association; De la Garza-Ramos
et al. found a relationship between the detection of H. pylori
in dental plaque and the depth of the periodontal pockets in
adults [48].
It is known that certain genotypes of H. pylori are related
to the severity of gastric pathology. Rudi et al. found that
H. pylori strains of the vacA s1 allele and the cagA gene are
more likely to result in peptic ulcer disease [49]. In Mexico,
Gonza´lez-Valencia et al. found that vacA s1 and cagA+ strains
were more frequent in adults than in children [50]. Another
study, conducted by Mart´ınez-Carrillo et al., confirmed that
vacA s1m1 genotypes are the most common in patients with
gastric ulcer and chronic gastritis [51]. However, Garza-
Gonzalez et al. found that the most frequent genotype was
s2m2 in H. pylori isolates from the northeastern region of
Mexico, but the s1m1 genotype was associated with cagA-
positive strains (𝑃 < 0.05) [52]. Our results show that the
H. pylori strains with the vacA s1m1 and s1m2 genotypes
are predominant in dental plaque from Mexican children
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without dyspeptic symptoms and agree with most of the
ones found inMexican patients with severe gastric pathology
[52, 53].
In another study, the most frequent genotype in the oral
cavity and gastric mucosa was vacA s1bm1 [54]. Roma´n-
Roma´n et al. found that 47/196 (24%) patientswere coinfected
(saliva and gastric biopsy).H. pylori vacA s1m1 or s1m2 geno-
types (either or both) were detected in 41.5% of the patients
with chronic gastritis. The s1m1/s1m2 genotypes, alone or
together, were found simultaneously in saliva and gastric
biopsy from the same patient [32]. These results and others
[33] support our findings; however, as far as we know this
is the first study of genotyping vacA in oral samples from
Mexican children without dyspepsia symptoms. Otherwise,
we found that s1m1/s1m2 genotypes alone or together were
mostly detected in participants with mild or moderate gin-
givitis (Table 4).
People infected with H. pylori who have a functional
cag-PAI have increased mucosal concentrations of IL8, neu-
trophilic infiltration into the gastric mucosa, and increased
risk of developing the gastric ulcer and cancer [29, 55,
56]; however other researchers did not agree to this [31].
Roma´n-Roma´n et al. conducted a study in a population from
Southern Mexico, and they observed an association between
H. pylori and the s1m1 genotype with gastric cancer, but cagA
was not associated with the diagnosis [57]. In our study, the
cagA status was related to the gingival clinical presentation
in H. pylori-positive children (𝑃 < 0.001). The s1m1/cagA+
or s1m2/cagA+ combinational genotypes alone or together
were mostly detected in dental plaque of children with mild
or moderate gingivitis. It is possible that these genotypes
play a role in the development of periodontal disease in
asymptomatic people with poor oral hygiene measures.
5. Conclusions
Our results demonstrate that H. pylori oral infection is
frequent among asymptomatic Mexican children and that,
in one individual, more than one H. pylori strain may exist
in dental plaque. The prevalence of H. pylori and detection
of some vacA/cagA genotypes-associated gastrointestinal dis-
ease in the oral cavity could be related to the progression of
gingivitis in children without dyspeptic symptoms.
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